UNICHEMLAB · Healthcare · Drug Manufacturers - Specialty & Generic
Composite scorecard: 54/100 — Quality 52 · Valuation 63 · Momentum 45
| Share price | ₹595.60 |
| Market cap | ₹4,497 Cr |
| P/E ratio | 17.8 |
| P/B ratio | 1.7 |
| ROE | 9.8% |
| Book value | ₹386.07 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹2,202 Cr | ₹253 Cr | 9.0% |
| 2025 | ₹2,111 Cr | ₹138 Cr | 13.0% |
| 2024 | ₹1,785 Cr | ₹-94 Cr | 5.0% |
| 2023 | ₹1,343 Cr | ₹-202 Cr | -3.0% |
| 2022 | ₹1,270 Cr | ₹33 Cr | 6.0% |
Unichem Laboratories Limited, a pharmaceutical company, manufactures and sells pharmaceutical products in India, the United States, and internationally. The company offers formulation products that address various therapeutic areas, such as gastroenterology, cardiology, diabetology, psychiatry, neurology, anti-bacterial, anti-infective, and pain management. It also offers active pharmaceutical ingredients, as well as contract manufacturing services. In addition, the company manufactures allopathic medicines, bulk drugs, and chemicals. It serves patients, distributors, health care professionals